Spectrum of SARS-CoV-2-Related Clinical Syndromes in Children: A Year in the Life

Mahjabeen Khan1,2, LeQuan Dang1,2, Harjinderpal Singh2

  • 1SSM Health Cardinal Glennon Children's Hospital, Saint Louis, MO, USA.

Clinical Pediatrics
|December 3, 2021
PubMed

Insights

Pediatric SARS-CoV-2 infections present diverse clinical pictures, including COVID-19 and MIS-C. Multisystem inflammatory syndrome in children (MIS-C) patients showed higher inflammatory markers and critical care needs compared to COVID-19.

Area of Science:

  • Pediatric Infectious Diseases
  • Viral Syndromes in Children
  • Public Health Surveillance

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits a broad clinical spectrum in pediatric populations.
  • Initial observations indicated milder symptoms in children, but the emergence of multisystem inflammatory syndrome in children (MIS-C) highlighted a more severe presentation.

Purpose of the Study:

  • To investigate the demographic and clinical characteristics of pediatric patients diagnosed with SARS-CoV-2-associated conditions.
  • To differentiate between coronavirus disease 2019 (COVID-19) and MIS-C based on clinical presentation and laboratory findings.

Main Methods:

  • Retrospective cohort study of hospitalized pediatric patients over one year.
  • Classification of patients into COVID-19 (non-MIS-C) and MIS-C cohorts based on clinical syndrome.
  • Analysis of demographic data, clinical symptoms, inflammatory markers, and patient outcomes.

Main Results:

  • Sixty-seven percent of SARS-CoV-2 positive patients were symptomatic.
  • Multisystem inflammatory syndrome in children (MIS-C) was diagnosed in 24 patients.
  • Both COVID-19 and MIS-C were more prevalent in Caucasian children, with distinct symptom profiles and inflammatory marker levels.
  • MIS-C patients exhibited significantly higher inflammatory markers, critical care requirements, and longer hospital stays.
  • COVID-19 cohort predominantly showed respiratory complications, whereas the MIS-C cohort presented with cardiovascular involvement.

Conclusions:

  • Pediatric SARS-CoV-2 infections manifest in distinct clinical syndromes: COVID-19 and MIS-C.
  • Multisystem inflammatory syndrome in children (MIS-C) is associated with heightened inflammation and critical illness, particularly cardiovascular complications.
  • Increased healthcare provider awareness is crucial for the early recognition, diagnosis, and timely management of both pediatric COVID-19 and MIS-C.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
680
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
482
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.0K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
957
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
59.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20